Patents by Inventor Xeve SILVER

Xeve SILVER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug delivery system and methods of using the same
    Patent number: 12642882
    Abstract: A method of preparing an implantable biomaterial includes combining a polymer with a neuro-regenerative agent or immunosuppressive agent selected from a group comprising at least one of: rapamycin, cyclosporine A, or analogs thereof, melting the polymer, and extruding the polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: June 2, 2026
    Assignee: Axogen Corporation
    Inventors: Kasra Tajdaran, Xeve Silver, Robert C. Diluccio
  • DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME
    Publication number: 20240197646
    Abstract: A method of preparing an implantable biomaterial film includes inputting a combination of a polymer and a neuro-regenerative agent or an immunosuppressive agent into an extruder. The method includes melting the polymer within the extruder. The method also includes extruding the combined polymer and the neuro-regenerative agent or the immunosuppressive agent to form the implantable biomaterial film.
    Type: Application
    Filed: December 15, 2023
    Publication date: June 20, 2024
    Applicant: Axogen Corporation
    Inventors: Kasra TAJDARAN, Justin DEUERLING, Angelo SCOPELIANOS, Xeve SILVER, Robert C. DILUCCIO, Nesreen ALSMADI
  • DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME
    Publication number: 20230190990
    Abstract: A method of preparing an implantable biomaterial includes combining a polymer with a neuro-regenerative agent or immunosuppressive agent selected from a group comprising at least one of: rapamycin, cyclosporine A, or analogs thereof, melting the polymer, and extruding the polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.
    Type: Application
    Filed: December 20, 2022
    Publication date: June 22, 2023
    Applicant: Axogen Corporation
    Inventors: Kasra TAJDARAN, Xeve SILVER, Robert C. DILUCCIO